MedTrace Logo

Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder

NCT01401413 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-07-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether the use of the drug ramelteon decreases the symptoms of REM Sleep Behavior Disorder.

Conditions

  • REM Sleep Behavior Disorder

Interventions

DRUG

ramelteon

8 mg nightly for 30 nights

DRUG

placebo

placebo control i pill nightly for 30 nights

Sponsors & Collaborators

  • Sleep Medicine Centers of WNY

    lead OTHER

Principal Investigators

  • Daniel I Rifkin, MD · Sleep medicine Centers of Western New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401413 on ClinicalTrials.gov